Exploration of a biomarker of Alzheimer's disease:G1/S checkpoint dysfunction in peripheral blood lymphocytes

周小英,张微微,刘扬,高旭光

DOI: https://doi.org/10.19845/j.cnki.zfysjjbzz.2018.12.009

2018-01-01

Abstract:Objective To further verify that cell cycle G1/S checkpoint dysfunction in neurons was also present in peripheral blood lymphocytes from Alzheimer's disease ( AD) subjects. To explore a novel biomarker of AD by detecting the function of G1/S checkpoint in AD subjects,normal ones and other common type of dementia subjects. Methods We selected 18 AD subjects as experimental group. 18 normal subjects,14 vascular dementia ( VaD) subjects and 12 subjects with other central nervous system degenerative disease such as Parkinson's disease and Parkinsonism-plus syndrome (PD/PPS) who showed dementia were selected as the three control groups. Peripheral lymphocytes were isolated from all sub-jects. After incubated with phytohemagglutinin (PHA) for 24 hours,cells were treated with rapamycin for another 24 hours (T48). G1% ,S% and G2% were respectively determined by flow cytometry to evaluate the function of G1/S checkpoint. Results G1% of T48cells in AD group was lower than normal group (P<0. 01),VaD group (P<0. 01) and PD/PPS group (P<0. 01). S% of T48cells in AD group was higher than normal group (P<0. 01),VaD group (P<0. 01) and PD/PPS group (P<0. 01). But there were no statistical differences of G1% and S% among controls (P>0. 05). G2% of T48cells in AD group was higher than VaD group (P<0. 01) and PD/PPS group (P<0. 01). But there were no statistical differences between AD group and normal group (P>0. 05). Conclusion G1/S checkpoint in lymphocytes from AD group failed to function. Cells distributions were consistent among normal group,VaD group and PD/PPS group. It suggested that G1/S checkpoint dysfunction might be unique to AD. Dysfunction of G1/S checkpoint in AD peripheral lymphocytes was ex-pected to be a novel blood biomarker for AD,and it might also provide a new therapeutic direction for AD.